COVID-19
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Asymptomatic infections or patients diagnosed as mild/normal/severe/critical according to COVID-19 Diagnosis and Treatment Protocol (Version 9); 2. At least 18 years old; 3. The TCM syndrome differentiation was divided into Yang deficiency and wet toxin not clear; 4. Informed consent signed by the patient or their legal representative.
Exclusion criteria
Exclusion criteria: 1. Currently participating in other clinical trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients with no progression of disease severity within 7 days; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to the TCM syndrome score 0;Proportion of patients transferred from makeshift accommodation to hospital within 7 days;;Proportion of disease severity without progression within 14 days;;Time to the symptom progression;;Percentage of patients with exacerbation and all-cause death within 14 days;;Time to persistent clinical symptoms disappear;;Percentage of patients with clinical symptoms disappeared;;Changes in COVID-19 symptom scores from baseline for patients with =1 score in any item on the baseline COVID-19 symptom scale;;Changes in single item score of COVID-19 related symptoms from baseline for patients with =1 score in any item on the baseline COVID-19 symptom scale;Changes of WHO Clinical Progress Scale score from baseline for patients with BASELINE WHO clinical Progress Scale score =1;Percentage of patients with baseline WHO CLINICAL Progress Scale score =1 decreased by at least 1 score from baseline;;Changes of SARS-COV-2 Ct value from baseline;Length of hospitalization;;Time to SARS-COV-2 NAAT negative;Changes in lymphocyte count, oxygen saturation (after 5 minutes of rest and exercise), oxygen concentration (FiO2), fatigue and sweating;Changes in chest CT scan image score from baseline at discharge; | — |
Countries
China